| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.11.1.2 |
| P698 | PubMed publication ID | 1987999 |
| P2093 | author name string | M A Austin | |
| P433 | issue | 1 | |
| P921 | main subject | triglyceride | Q186319 |
| P304 | page(s) | 2-14 | |
| P577 | publication date | 1991-01-01 | |
| P1433 | published in | Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 |
| P1476 | title | Plasma triglyceride and coronary heart disease | |
| P478 | volume | 11 |
| Q79212069 | A Common Truncated Variant of Lipoprotein Lipase in the Japanese Population Is Characterized by Pattern B Phenotype |
| Q41495179 | A brief review paper of the efficacy and safety of atorvastatin in early clinical trials |
| Q37268111 | A cerebrovascular perspective of atherosclerosis |
| Q37365645 | A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease |
| Q44043014 | A lipoprotein lipase activator, NO-1886 prevents impaired endothelium-dependent relaxation of aorta caused by exercise in aged rats |
| Q74819874 | A lipoprotein lipase activator, NO-1886, improves endothelium-dependent relaxation of rat aorta associated with aging |
| Q57533782 | A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients witb hypercholesterolemia |
| Q45110557 | A randomized trial of the effects of atorvastatin and niacin in patients with combined hyperlipidemia or isolated hypertriglyceridemia. Collaborative Atorvastatin Study Group |
| Q51560983 | A successful dietary treatment fails to normalize plasma triglyceride postprandial response in type IV patients. |
| Q33751628 | AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology |
| Q70624170 | Abnormal distribution of VLDL subfractions in type 1 (insulin-dependent) diabetic patients: could plasma lipase activities play a role? |
| Q41214587 | Age-related changes affecting atherosclerotic risk. Potential for pharmacological intervention |
| Q45041780 | Alcohol dose and low density lipoprotein heterogeneity in squirrel monkeys (Saimiri sciureus) |
| Q36951647 | Altered relationship of plasma triglycerides to HDL cholesterol in patients with HIV/HAART-associated dyslipidemia: further evidence for a unique form of metabolic syndrome in HIV patients. |
| Q24562942 | An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms |
| Q72131283 | An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population |
| Q40482679 | An update on coronary risk factors |
| Q35889081 | Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations |
| Q42576522 | Apolipoproteins and diabetic retinopathy |
| Q57337171 | Association of apolipoprotein (Apo)E genotype with plasma apo E levels |
| Q50959234 | Association of lipoprotein cholesterol and triglycerides with the severity of coronary artery disease in men and women. |
| Q72245160 | Associations between serum lipids and indicators of adiposity in men with spinal cord injury |
| Q35651476 | Atherosclerosis and physical activity |
| Q41454232 | Atorvastatin. A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias |
| Q73155572 | Baseline risk factors and their association with outcome in the West of Scotland Coronary Prevention Study. The West of Scotland Coronary Prevention Study Group |
| Q36449465 | Bio F1B hamster: a unique animal model with reduced lipoprotein lipase activity to investigate nutrient mediated regulation of lipoprotein metabolism |
| Q46546890 | Blood lipid response to 20 weeks of supervised exercise in a large biracial population: the HERITAGE Family Study |
| Q61684253 | Cardiovascular prognosis in relation to apolipoproteins and other lipid parameters in patients with stable angina pectoris treated with verapamil or metoprolol: results from the Angina Prognosis Study in Stockholm (APSIS) |
| Q77299202 | Cerivastatin in the treatment of mixed hyperlipidemia: the RIGHT study. The Cerivastatin Study Group. Cerivastatin Gemfibrozil Hyperlipidemia Treatment |
| Q74348132 | Cilostazol, a selective type III phosphodiesterase inhibitor, decreases triglyceride and increases HDL cholesterol levels by increasing lipoprotein lipase activity in rats |
| Q33578646 | Clinical considerations and mechanistic determinants of postprandial lipemia in older adults |
| Q40482684 | Clinical perspectives on primary and secondary prevention of coronary atherosclerosis |
| Q41726692 | Clinical pharmacokinetics of fibric acid derivatives (fibrates). |
| Q40440943 | Clustering of cardiovascular risk factors: Targeting high-risk individuals |
| Q34170860 | Coincidence of genetic loci for plasma cholesterol levels and obesity in a multifactorial mouse model |
| Q35017838 | Combination therapy for combined dyslipidemia |
| Q43847641 | Comparison of metabolic risk profiles between subjects with fasting and 2-hour plasma glucose impairment: The Kinmen Study |
| Q28378668 | Comparison of quinapril and atenolol as single drugs or in combination with hydrochlorothiazide in moderate to severe hypertensives, using automated ambulatory monitoring |
| Q53903837 | Comparison of the efficacy and tolerability of simvastatin and atorvastatin in the treatment of hypercholesterolemia. |
| Q70975000 | Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia |
| Q52216943 | Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins. |
| Q40843204 | Current and future treatment of hyperlipidemia: the role of statins |
| Q33959900 | Detection of quantitative trait loci affecting serum cholesterol, LDL, HDL, and triglyceride in pigs |
| Q74601035 | Development and evaluation of a direct sandwich enzyme-linked immunosorbent assay for the quantification of lipoprotein lipase mass in human plasma |
| Q36600125 | Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational study |
| Q44014870 | Dietary restriction reduces atherosclerosis and oxidative stress in the aorta of apolipoprotein E-deficient mice |
| Q51564572 | Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease. |
| Q74313798 | Effect of KRN4884 on lipid metabolism in hyperlipidemic rats |
| Q46094863 | Effect of bezafibrate on office, home and ambulatory blood pressure in hypertensive patients with dyslipidemia |
| Q51577517 | Effect of dietary versus pharmacological correction of hypertriglyceridemia on red blood cell membrane sodium/lithium countertransport activity. |
| Q37229818 | Effect of green tea extract microencapsulation on hypertriglyceridemia and cardiovascular tissues in high fructose-fed rats |
| Q39633792 | Effect of insulin on the differential expression of VLDL receptor isoforms of SGC7901 cell and its biological implication. |
| Q51571610 | Effect of modified dairy fat on postprandial and fasting plasma lipids and lipoproteins in healthy young men. |
| Q42266899 | Effects of KRN4884, a novel pyridinecarboxamidine type KATP channel opener, on serum triglyceride levels in rats |
| Q51570095 | Effects of adding C-19 versus C-21 progestin to conjugated estrogen in moderately hypercholesterolemic postmenopausal women. |
| Q43612137 | Effects of bezafibrate and simvastatin on plasma lipoproteins in hypercholesterolemia resistant to hormone replacement therapy |
| Q47311518 | Effects of dietary fat restriction on particle size of plasma lipoproteins in postmenopausal women |
| Q73873919 | Effects of ethyl-all-cis-5,8,11,14,17-icosapentaenoate (EPA-E), pravastatin and their combination on serum lipids and intimal thickening of cuff-sheathed carotid artery in rabbits |
| Q51385106 | Egg consumption as part of an energy-restricted high-protein diet improves blood lipid and blood glucose profiles in individuals with type 2 diabetes. |
| Q44007594 | Epidemiology of hypertriglyceridemia and cardiovascular disease |
| Q40802371 | Epidemiology of triglycerides, small dense low-density lipoprotein, and lipoprotein(a) as risk factors for coronary heart disease |
| Q68201409 | Evidence for mechanisms of the hypotriglyceridemic effect of n − 3 polyunsaturated fatty acids |
| Q72779087 | Extracoronary atherosclerosis and genetic variants of apolipoprotein AI-CIII cluster in myocardial infarction survivors from southern Italy |
| Q36012834 | Fasting serum triglyceride and high-density lipoprotein cholesterol levels in patients intended to be treated for dyslipidemia |
| Q42283686 | Fenofibrate improves postprandial chylomicron clearance in II B hyperlipoproteinemia |
| Q73477801 | Fibrinolytic response in subjects with hypertriglyceridemia and low HDL cholesterol |
| Q74211805 | Fractional removal rate of fat emulsion (K2) remains to be low in APOE3/3 phenotype subjects with serum triglyceride level above 180mg/dl |
| Q34384365 | From interaction of lipidic vehicles with intestinal epithelial cell membranes to the formation and secretion of chylomicrons |
| Q34983204 | Fruits and vegetables moderate lipid cardiovascular risk factor in hypertensive patients |
| Q46732799 | Function and significance of very low density lipoprotein receptor subtype II. |
| Q40436410 | Genetic Determinants of Myocardial Infarction |
| Q77452737 | Genetics of lipoprotein disorders |
| Q34133528 | HDL-cholesterol as a marker of coronary heart disease risk: the Québec cardiovascular study. |
| Q36321840 | Health Claims: Omega-3 Fatty Acids and Cardiovascular Disease |
| Q47832833 | Hematocrit and hemoglobin are independently related to insulin resistance and compensatory hyperinsulinemia in healthy, non-obese men and women |
| Q44472984 | Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study |
| Q35152178 | High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions |
| Q71517631 | High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia |
| Q51554081 | Homeostasis model assessment in a population with mixed ethnicity: the 1992 Singapore National Health Survey. |
| Q31886533 | Homocysteine and lipid lowering agents. A comparison between atorvastatin and fenofibrate in patients with mixed hyperlipidemia |
| Q64999111 | Human lipoprotein lipase HindIII polymorphism in young patients with myocardial infarction. |
| Q54081357 | Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited. |
| Q33900976 | Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice |
| Q44268486 | Hypertriglyceridemia as a cardiovascular risk factor |
| Q40864746 | Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome |
| Q73887951 | Hypertriglyceridemia: new insights and new approaches to pharmacologic therapy |
| Q34027319 | Identification and treatment of hypertriglyceridemia as a risk factor for coronary heart disease |
| Q36816891 | Identification of patients at high risk for adverse coronary events while awaiting routine coronary angioplasty |
| Q35210500 | Impact of dyslipidemia on cardiovascular risk stratification of hypertensive patients and association of lipid profile with other cardiovascular risk factors: results from the ICEBERG study. |
| Q51574954 | Impacts of components of the metabolic syndrome on health status and survival in an aged population. |
| Q61921761 | In Situ Monitoring of Nanostructure Formation during the Digestion of Mayonnaise |
| Q35751599 | Increased production rates of LDL are common in individuals with low plasma levels of HDL cholesterol, independent of plasma triglyceride concentrations |
| Q50931423 | Influence of fitness status on very-low-density lipoprotein subfractions and lipoprotein(a) in men and women. |
| Q35263542 | Influence of genetic variants in the apolipoprotein A5 and C3 gene on lipids, lipoproteins, and its association with coronary artery disease in Indians |
| Q73384085 | Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels |
| Q40561201 | Insights into the pathogenesis and prevention of coronary artery disease. |
| Q51590370 | Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM. |
| Q40812885 | Insulin resistance and risk factors for coronary heart disease |
| Q40560110 | Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease |
| Q77494999 | Interactive effects of increased intake of saturated fat and cholesterol on atherosclerosis in the Japanese quail (Coturnix japonica) |
| Q73565107 | Intermediate density lipoprotein cholesterol as the best lipoprotein predictor of atherosclerosis severity in the Watanabe Heritable Hyperlipidemic rabbit |
| Q51565523 | Interrelationships between postprandial lipoprotein B:CIII particle changes and high-density lipoprotein subpopulation profiles in mixed hyperlipoproteinemia. |
| Q37048435 | Intestinally-derived lipoproteins: Metabolism and clinical significance |
| Q43545510 | Left ventricular mass and correlated atherosclerotic risk factors in young adolescents: report from Chin-Shan community cardiovascular study in Taiwan. |
| Q44621116 | Life Style and Cardiovascular Risk Factors in the Japanese Population-From an Epidemiological Survey on Serum Lipid Levels in Japan 1990. Part 1: Influence of Life Style and Excess Body Weight on HDL-Cholesterol and Other Lipid Parameters in Men |
| Q82092271 | Lipid lowering in patients with coronary artery disease: low density lipoprotein cholesterol and beyond |
| Q35045471 | Lipid-lowering properties of TAK-475, a squalene synthase inhibitor, in vivo and in vitro |
| Q41556858 | Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus |
| Q34990631 | Lipoprotein abnormalities related to women's health |
| Q73252781 | Lipoprotein lipase activation by red ginseng saponins in hyperlipidemia model animals |
| Q40912350 | Lipoprotein metabolism and renal failure |
| Q40868237 | Lipoprotein metabolism in normal and uremic patients |
| Q51566076 | Magnitude of alimentary lipemia is related to intima-media thickness of the common carotid artery in middle-aged men. |
| Q33843614 | Management of selected lipid abnormalities. Hypertriglyceridemia, low HDL cholesterol, lipoprotein(a), in thyroid and renal diseases, and post-transplantation |
| Q35585949 | Management of selected lipid abnormalities: hypertriglyceridemia, isolated low HDL-cholesterol, lipoprotein(a), and lipid abnormalities in renal diseases and following solid organ transplantation |
| Q36281073 | Methods for studying rodent intestinal lipoprotein production and metabolism |
| Q57180253 | Multiple reaction monitoring (MRM)-profiling with biomarker identification by LC-QTOF to characterize coronary artery disease |
| Q77463122 | Negative and independent influence of apolipoprotein E on C-reactive protein (CRP) concentration in obese adults. Potential anti-inflammatory role of apoE in vivo |
| Q70824888 | No association of apolipoprotein A-IV codon 347 and 360 variation with atherosclerosis and lipid transport in a sample of mixed hyperlipidemics |
| Q34349018 | Nonfasting triglycerides and risk of cardiovascular death in men and women from the Norwegian Counties Study |
| Q34438259 | Obesity and disease management: effects of weight loss on comorbid conditions |
| Q36300187 | Obesity and lipids |
| Q40389357 | Omega-3 fatty acids. Current status in cardiovascular medicine |
| Q79762017 | Overproduction of intestinal lipoprotein containing apolipoprotein B-48 in Psammomys obesus: impact of dietary n-3 fatty acids |
| Q36265744 | Oxidant status and lipid profile in vegetarians and fish eaters |
| Q42714792 | Oxidised LDL, HDL cholesterol, LDL cholesterol levels in patients of coronary artery disease |
| Q37701749 | Paclitaxel and platinum-based chemotherapy results in transient dyslipidemia in cancer patients |
| Q34725115 | Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. Canadian Heart Health Surveys Research Group |
| Q33898251 | Plasma triglycerides determine low density lipoprotein composition, physical properties, and cell-specific binding in cultured cells |
| Q40458696 | Postmenopausal Hormone-Replacement Therapy and Cardiovascular Risk |
| Q35992933 | Postprandial lipemia in pre- and postmenopausal women |
| Q36516841 | Prescribing aerobic exercise for the regulation of postprandial lipid metabolism : current research and recommendations |
| Q74046259 | Presence of vitamin K-dependent coagulation proteins in isolated triglyceride-rich lipoproteins of human plasma |
| Q52338508 | Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Québec Cardiovascular Study) |
| Q34003407 | Preventing, stopping, or reversing coronary artery disease--triglyceride-rich lipoproteins and associated lipoprotein and metabolic abnormalities: the need for recognition and treatment |
| Q51571566 | Production of small high-density lipoprotein particles after stimulation of in vivo lipolysis in hypertriglyceridemic individuals: studies before and after triglyceride-lowering therapy. |
| Q41742306 | Profiling risk and new therapeutic interventions: looking ahead |
| Q39603968 | Proinsulin and insulin responses to a mixed meal in hypertriglyceridaemic men. |
| Q34107158 | Recent developments in the treatment of hypertriglyceridemia |
| Q28066150 | Regular-Fat Dairy and Human Health: A Synopsis of Symposia Presented in Europe and North America (2014-2015) |
| Q46712278 | Relationship between C peptide and chronic complications in type-2 diabetes mellitus. |
| Q37048431 | Relationship between diabetic dyslipoproteinaemia and coronary heart disease risk in subjects with non-insulin-dependent diabetes mellitus |
| Q51599356 | Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic men. |
| Q33672134 | Relationship of adiposity to the population distribution of plasma triglyceride concentrations in vigorously active men and women |
| Q51564742 | Relationship of glucose and insulin levels to the risk of myocardial infarction: a case-control study. |
| Q43654229 | Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment |
| Q73165138 | Remnant-like very-low-density lipoprotein isolated from hypertriglyceridemic patients by immunoaffinity chromatography suppressed 3-hydroxy-3-methylglutaryl coenzyme A activity of cultured human skin fibroblasts |
| Q47987205 | Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation |
| Q35904825 | Role of fibric acid derivatives in the management of risk factors for coronary heart disease |
| Q31942452 | Safety and effectiveness of Niaspan when added sequentially to a statin for treatment of dyslipidemia |
| Q59601155 | Serum From Magnesium-Deficient Rats Affects Vascular Endothelial Cells in Culture: Role of Hyperlipemia and Inflammation |
| Q51573934 | Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. |
| Q39652119 | Serum lipid levels in an Iranian adults population: Tehran Lipid and Glucose Study. |
| Q37279888 | Studying the Relation of Postprandial Triglyceride with Coronary Artery Disease (CAD). |
| Q94278550 | Sugar |
| Q37107873 | Taking nutritional supplements for three months reduced blood pressure but not blood lipid levels in students |
| Q72350744 | The acute effects of a single very high dose of n-3 fatty acids on plasma lipids and lipoproteins in healthy subjects |
| Q57812629 | The conjoint trait of low high-density lipoprotein cholesterol and high triglycerides in adolescent black and white males |
| Q40747951 | The effect of a gender difference in the apolipoprotein E gene DNA polymorphism on serum lipid levels in a Serbian healthy population |
| Q40521981 | The fourth musketeer--from Alexandre Dumas to Claude Bernard |
| Q35920789 | The health consequences of smoking. Cardiovascular diseases |
| Q31869703 | The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding |
| Q34729970 | The insulin resistance-dyslipidemia syndrome: the most prevalent cause of coronary artery disease? |
| Q71804762 | The lipid-lowering effects of atorvastatin, a new HMG-CoA reductase inhibitor: results of a randomized, double-masked study |
| Q34113923 | The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis |
| Q35794818 | The prevalence, awareness and treatment of high low density lipoprotein-cholesterol in korean adults without coronary heart diseases - the third Korea national health and nutrition examination survey, 2005 -. |
| Q43704005 | The rise of the plasma lipid concentration elicited by dietary sodium chloride restriction in Wistar rats is due to an impairment of the plasma triacylglycerol removal rate. |
| Q77452760 | The role of cholesterol management in coronary disease risk reduction in elderly patients |
| Q34435090 | The role of fasting versus non-fasting triglycerides in ischemic stroke: a systematic review |
| Q34109473 | The role of fibric acids in atherosclerosis |
| Q35670974 | The role of functional foods, nutraceuticals, and food supplements in intestinal health |
| Q51551454 | The small, dense LDL phenotype as a correlate of postprandial lipemia in men. |
| Q34107409 | Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype |
| Q34181381 | Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management |
| Q34027254 | Triglycerides and coronary risk |
| Q37244736 | Triglycerides and risk for coronary artery disease |
| Q24618902 | Triglycerides as vascular risk factors: new epidemiologic insights |
| Q51012566 | Very low density lipoprotein subfraction abnormalities in IDDM patients: any effect of blood glucose control? |
| Q39528844 | What should we do about Hypertriglyceridemia in Coronary Artery Disease Patients? |
| Q40560119 | Why can high insulin levels indicate a risk for coronary heart disease? |
| Q52416411 | [How many patients need treatment for hypercholesterolemia?]. |
| Q40886823 | von Willebrand factor and soluble E-selectin in the prediction of cardiovascular disease progression in hyperlipidaemia |
Search more.